¼¼°èÀÇ °­¾ÐÁ¦ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Anti-Hypertensive Drug Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1649496
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 144 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,715,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,583,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °­¾ÐÁ¦½ÃÀåÀº CAGR 2.88%·Î ¼ºÀåÇϸç, ½ÃÀå ±Ô¸ð´Â 2025³â 410¾ï 8,200¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 472¾ï 4,100¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°­¾ÐÁ¦ ½ÃÀåÀº °Ç°­¿¡ ÇØ·Î¿î »ýȰ½À°ü°ú °ü·ÃµÈ °íÇ÷¾Ð À¯º´·ü Áõ°¡·Î ÀÎÇØ ÇâÈÄ 5³â°£ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ Áõ°¡´Â ³ëÀεéÀÌ ÀþÀº »ç¶÷µé¿¡ ºñÇØ °íÇ÷¾Ð¿¡ °É¸®±â ½±±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¾àǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °íÇ÷¾ÐÀº Àü ¼¼°è¿¡¼­ Á¶±â»ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °íÇ÷¾Ð Áõ°¡¿¡´Â °úµµÇÑ Èí¿¬, ¸¸¼º ½ºÆ®·¹½º, ¸¸¼º ½ÅÀåÁúȯ, ´Ù·®ÀÇ ¾ËÄÚ¿Ã ¼·Ãë, ºñ¸¸ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ °ü¿©ÇÕ´Ï´Ù. ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ëÀÇ Èí¿¬ÀÚ ¹× À½ÁÖÀÚ Áõ°¡´Â ÀÌ·¯ÇÑ »ýȰ½À°ü ¼±ÅÃÀ¸·Î ÀÎÇÑ °íÇ÷¾Ð ¹ßº´·ü Áõ°¡°¡ ¿¹»ó¿¡ µû¶ó ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¼ºÀÎ ºñ¸¸À² Áõ°¡´Â ÇâÈÄ ¼ö³â°£ °­¾ÐÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í ¼¼°èÈ­·Î ÀÎÇØ °øÁß º¸°Ç »óŵµ ¾ÇÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­, ½ºÆ®·¹½º ¼öÁØ Áõ°¡, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü ¹× ¼ö¸é ½À°üÀº Ç÷¾Ð »ó½ÂÀÇ ÇÑ ¿äÀÎÀ¸·Î ÇâÈÄ 5³â µ¿¾È °­¾ÐÁ¦ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°­¾ÐÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ

Áö¿ªÀû Àü¸Á

¿ä¾àÇϸé, °­¾ÐÁ¦ ½ÃÀåÀº °íÇ÷¾Ð À¯º´·ü Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áö¿ªÀûÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ºÏ¹Ì°¡ °Ç°­ °á°ú¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¶Ñ·ÇÇÑ »çȸ°æÁ¦Àû ¿äÀÎÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸¸ÅÇØ¾ß ÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ¼¼°èÀÇ °­¾ÐÁ¦ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°

Á¦6Àå ¼¼°èÀÇ °­¾ÐÁ¦ ½ÃÀå : À¯Çüº°

Á¦7Àå ¼¼°èÀÇ °­¾ÐÁ¦ ½ÃÀå : ÆÇ¸Åä³Îº°

Á¦8Àå ¼¼°èÀÇ °­¾ÐÁ¦ ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global anti-hypertensive drug market is estimated to grow at a CAGR of 2.88% to reach a market size of US$47.241 billion in 2030 from US$41.082 billion in 2025.

The global anti-hypertensive drug market is expected to experience significant growth over the next five years, driven by the increasing prevalence of hypertension linked to unhealthy lifestyles. Additionally, the growing geriatric population is a major factor contributing to the rising demand for these medications, as older adults are more prone to high blood pressure compared to younger individuals. Hypertension is a leading cause of premature deaths worldwide.Several factors contribute to the rise in high blood pressure, including excessive smoking, chronic stress, chronic kidney disease, high alcohol consumption, and obesity. The increasing number of smokers and alcohol consumers, particularly among millennials, is projected to create substantial growth opportunities for the market as hypertension rates are expected to rise due to these lifestyle choices. Furthermore, the growing obesity rates among adults will likely drive demand for anti-hypertensive drugs in the coming years.Rapid urbanization and globalization are also deteriorating public health conditions. Changing lifestyles, increased stress levels, and unhealthy eating and sleeping habits contribute to higher blood pressure, which is anticipated to positively influence the growth of the anti-hypertensive drug market over the next five years.

Key Drivers of the Global Anti-Hypertensive Drug Market

Geographical Outlook

In summary, the global anti-hypertensive drug market is set for substantial growth driven by rising hypertension prevalence and an aging population. Geographically, both Asia Pacific and North America are expected to play crucial roles in this expansion due to distinct socio-economic factors influencing health outcomes.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Market Segmentation:

The global anti-hypertensive drug market is segmented and analyzed as below:

By Drug Class

By Type

By Sales Channel

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. GLOBAL ANTI-HYPERTENSIVE DRUG MARKET BY DRUG CLASS

6. GLOBAL ANTI-HYPERTENSIVE DRUG MARKET BY TYPE

7. GLOBAL ANTI-HYPERTENSIVE DRUG MARKET BY SALES CHANNEL

8. GLOBAL ANTI-HYPERTENSIVE DRUG MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â